logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. The affordability of antiretroviral therapy in developing countries : what policymakers need to know.

    Article - En anglais

    Objective 

    The objective of this paper is to assist policymakers in developing countries and international donors by providing an outline of economic information needed to make a decision regarding the purchase of drugs to provide highly active antiretroviral therapy (HAART).

    Design 

    The following paper : (i) reviews existing experiences of policymakers in developing countries regarding the purchase of drugs needed for HAART, (ii) identifies issues that would need to be addressed and data that would be required to make more informed decisions regarding this issue, (iii) develops a cost-benefit model that could be utilized in designing an economic research project evaluating the economic costs and benefits of HAART, and (iv) performs a preliminary test of this model with data from Costa Rica.

    Results 

    A review of experiences with this issue reveals that there are growing political, legal and budgetary pressures for countries to make tenable decisions regarding the purchase of drugs for HAART.

    An economic model describing the costs and benefits of HAART is proposed, although much of the required data for using such a model is currently neither available or in the process of being collected.

    Conclusions 

    It is imperative that economic data be collected to better inform policymakers in developing countries about their decision regarding the purchase of these drugs. (...)

    Mots-clés Pascal : SIDA, Virose, Infection, Chimiothérapie, Traitement, Antiviral, Pays en développement, Politique sanitaire, Aspect économique, Analyse avantage coût, Modélisation, Modèle économique, Homme, Immunopathologie, Immunodéficit, Economie santé, Protocole HAART

    Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Chemotherapy, Treatment, Antiviral, Developing countries, Health policy, Economic aspect, Cost benefit analysis, Modeling, Economic model, Human, Immunopathology, Immune deficiency, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0025113

    Code Inist : 002B05C02D. Création : 31/05/1999.